CEFTOCIDIN Line : Acute and Dry Mastitis. Supported by an original development proud to be the first intramammary with cephalexin in the veterinary field.
First choice synergistic antibiotic combination.
01.
Very low dose of Prednisolone, which seeks to reduce the scar response and loss of functioning tissue. Rapid release excipient , allowing high concentrations of antibiotic without the persistence of residues for long periods and the consequent loss of use of milk.
Healing effect and prophylactic effect.
02.
The slow-release base is completely harmless to breast tissue; evaluated in healthy suckler dairy cows in mid-lactation. Its use in cows that start the drying period prevents infections during this period and minimizes the risks of the next lactation . In addition, it exerts a very important curative action for subclinical mastitis.
INJECTOR WITH
RING
FLEXION
The “injector with flexing rings”, specially developed and patented by Laboratorio FUNDACION, prevents the nipple duct from being injured, no matter how hard or abrupt its introduction. Do not scrape and do not puncture, guaranteeing the protection of the nipple mucosa.
library
OUR PUBLICATIONS
→ FIRST EPISODE CLINICAL STAPHYLOCOCCUS AUREUS MASTITIS. COMPARISON OF TWO INTRAMAMMARY 3-DAY TREATMENTS.
Only
Cura
USE IN
-
Both products are presented in athermic boxes containing 20
sterile injectors.
Each injector is enclosed in a hermetic packaging whose material preserves its sterility. Irradiated Product in the National Atomic Energy Commission.
